DaVita HealthCare Partners Inc (DVA)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 936,342 | 827,678 | 859,622 | 815,637 | 691,535 | 608,973 | 467,707 | 513,825 | 560,400 | 679,770 | 834,158 | 903,169 | 978,450 | 964,750 | 863,670 | 771,452 | 773,642 | 844,740 | 829,336 | 901,285 |
| Total stockholders’ equity | US$ in thousands | 121,122 | 386,715 | 632,900 | 925,997 | 1,056,100 | 1,199,200 | 1,017,440 | 825,470 | 712,326 | 532,672 | 604,784 | 843,771 | 755,508 | 1,149,440 | 1,277,780 | 1,248,110 | 1,383,570 | 1,574,760 | 2,153,920 | 1,947,850 |
| ROE | 773.06% | 214.03% | 135.82% | 88.08% | 65.48% | 50.78% | 45.97% | 62.25% | 78.67% | 127.62% | 137.93% | 107.04% | 129.51% | 83.93% | 67.59% | 61.81% | 55.92% | 53.64% | 38.50% | 46.27% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $936,342K ÷ $121,122K
= 773.06%
DaVita HealthCare Partners Inc's Return on Equity (ROE) has shown significant fluctuations over the period analyzed. The ROE increased consistently from March 31, 2020, to June 30, 2021, reaching a peak of 137.93% in June 30, 2022. This upward trend indicates the company's ability to generate strong returns for its shareholders relative to its equity base.
However, the ROE experienced a sharp decline in the subsequent quarters, dropping to 45.97% by June 30, 2023, and then recovering slightly in the following periods. The sudden fluctuations in ROE suggest potential changes in the company's financial performance, capital structure, or operational efficiency.
Of note is the significant surge in ROE to 773.06% by December 31, 2024. While such a high ROE may indicate robust financial performance, it could also raise questions about the sustainability and consistency of these returns.
Overall, the varying ROE values underline the importance of closely monitoring DaVita HealthCare Partners Inc's financial performance and evaluating the factors driving these fluctuations to gain a deeper understanding of the company's profitability and efficiency in utilizing its shareholders' equity.
Peer comparison
Dec 31, 2024